Intec Pharma Appoints U.S. Life Sciences Executive Jeffrey A. Meckler to its Board of Directors as Vice Chairman

JERUSALEM, April 9, 2017 /PRNewswire/ — Intec Pharma Ltd. (NTEC), a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill™ platform technology, today announced the appointment of Jeffrey A. Meckler as Vice Chairman of its Board of Directors, effective immediately. 

“We are delighted to welcome Jeff to the Intec Board,” commented John W. Kozarich, Ph.D., Chairman of the Board of Intech Pharma. “Jeff’s rich industry experience and insights into corporate development strategies are renowned in the industry. Our innovative drug delivery platform technology will benefit greatly from Jeff’s efforts. In addition, his joining the Intec Pharma team dovetails with our goal to extend the U.S. and global footprint of Intec and enhance the broader recognition of our technology.”

Mr. Meckler brings to Intec Pharma more than 25 years of life sciences executive

... read more at: http://finance.yahoo.com/news/intec-pharma-appoints-u-life-061500882.html